FYI from the NHLBI Index

May 2009: Vol. 10, Issue 1
Research and Resources

Biomedical Research on the International Space Station (BioMed-ISS) (UH2/UH3)
Career Enhancement Award for Stem Cell Research (K18)
Centers for AIDS Research: D-CFAR, CFAR (P30)
Childhood Obesity Prevention and Treatment Research Consortium (U01)
Community-Based Partnerships for Childhood Obesity Prevention and Control: Research to Inform Policy (R21)
Exploratory/Developmental Clinical Research Grants in Obesity (R21)
NHLBI Career Transition Award (K22)
NHLBI Progenitor Cell Biology Consortium Research Hubs (U01) and Consortium Administrative Coordinating Center (U01)
Pharmacogenomics Research Network (U01/U19)
Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01)
Prematurity and Respiratory Outcomes Program (PROP) (U01)
Recovery Act Limited Competition for NIH Grants: Research and Research Infrastructure "Grand Opportunities" (RC2)
Recovery Act Limited Competition: Supporting New Faculty Recruitment to Enhance Research Resources through Biomedical Research Core Centers (P30)

NHLBI Research Initiatives

From time to time, the NHLBI invites investigators to submit grant applications or contract proposals for specific research programs. We are soliciting applications for the new programs described below. Please visit the URL listed with each program to obtain information about important application dates and deadlines. For full details of these and other current research initiatives, visit www.nhlbi.nih.gov/funding/inits/index.htm.

Biomedical Research on the International Space Station (BioMed-ISS) (UH2/UH3)

Initiative Number: PAR-09-120
Objective: Use the unique microgravity and radiation environment and resources of the International Space Station to test innovative hypotheses relevant to the NHLBI mission.

Career Enhancement Award for Stem Cell Research (K18)

Initiative Number: PA-09-110
Objective: Provide investigators with the opportunity to acquire new research capabilities in the use of human or animal embryonic, adult, or cord blood stem cells.

Centers for AIDS Research: D-CFAR, CFAR (P30)

Initiative Number: PAR-09-103
Objective: Provide infrastructure and promote basic, clinical, behavioral, and translational AIDS research activities at institutions that receive significant AIDS funding from multiple NIH Institutes or Centers.

Childhood Obesity Prevention and Treatment Research Consortium (U01)

Initiative Number: HL-10-004/005
Objective: Test the efficacy of interventions to prevent excess weight gain in normal-weight children ages 1-10 years, prevent additional weight gain in obese youth ages 11-18, and/or facilitate weight loss in obese youth ages 11-18.

Community-Based Partnerships for Childhood Obesity Prevention and Control: Research to Inform Policy (R21)

Initiative Number: PA-09-141
Objective: Enhance childhood obesity research by forming local, state, or regional teams of researchers, policymakers, and other relevant stakeholders such as community representatives, public health practitioners, and educators.

Exploratory/Developmental Clinical Research Grants in Obesity (R21)

Initiative Number: PA-09-124
Objective: Conduct exploratory/developmental clinical studies that will accelerate the development of effective interventions for prevention or treatment of overweight or obesity in either adults or children.

NHLBI Career Transition Award (K22)

Initiative Number: PAR-09-102
Objective: Enable outstanding students with three to five years of postdoctoral training to obtain research training experience in the NHLBI Division of Intramural Research and facilitate their successful transition to an extramural environment as independent researchers.

NHLBI Progenitor Cell Biology Consortium Research Hubs (U01) and Consortium Administrative Coordinating Center (U01)

Initiative Number: HL-09-004/005
Objective: Identify and characterize progenitor cell lineages, direct the differentiation of stem and progenitor cells to desired cell fates, and develop new strategies to address the challenges presented by transplantation of these cells.

Pharmacogenomics Research Network (U01/U19)

Initiative Number: GM-10-001
Objective: Conduct research to understand the genetic basis of variable drug responses, both therapeutic and adverse.

Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01)

Initiative Number: HL-10-003
Objective: Conduct phase II clinical treatment trials of innovative agents for lung diseases and sleep disorders.

Prematurity and Respiratory Outcomes Program (PROP) (U01)

Initiative Number: HL-10-007
Objective: Develop strategies to phenotype premature infants ready for discharge from the neonatal intensive care unit in order to identify functional and molecular biomarkers of respiratory disease risk.

Recovery Act Limited Competition for NIH Grants: Research and Research Infrastructure "Grand Opportunities" (RC2)

Initiative Number: RFA-OD-09-004
Objective: Undertake large, specific biomedical and biobehavioral research endeavors that will benefit from significant 2-year funds without the expectation of continued NIH funding beyond two years.

Recovery Act Limited Competition: Supporting New Faculty Recruitment to Enhance Research Resources through Biomedical Research Core Centers (P30)

Initiative Number: RFA-OD-09-005
Objective: Augment and expand Biomedical Core Centers through the hiring of newly independent investigators.

Modified 5/29/09
[Back to Top]
[Table of Contents]

Need More Information?

We are always interested in receiving comments and suggestions from the community. If you or your organizations have questions for me or for the Institute, please contact me at nabele@nhlbi.nih.gov or Dr. Carl Roth at rothc@nhlbi.nih.gov.

Elizabeth G. Nabel, M.D.
Director, NHLBI

For information on specific issues, the following contacts may be helpful:

For health related questions and publications, please contact the trained information specialists at the NHLBI Information Center (NHLBIinfo@nhlbi.nih.gov) or write to the Information Center at P.O. Box 30105, Bethesda, MD 20824-0105.

For communications pertaining to NHLBI policies and priorities, contact the NHLBI Office of Public Liaison, (nhlbi.listens@nih.gov).

For additional information regarding NHLBI events, consult the references provided or NHLBI Calendar. Most other NIH Institutes and Centers also maintain calendars on their Web sites. Links to their Web pages are at NIH Institutes, Centers, and Offices.

For Web related matters pertaining to the online version of the FYI from the NHLBI, contact the FYI from the NHLBI's Web Editor.

Please send us your feedback, comments, and questions by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.